Form 8-K - Current report:
SEC Accession No. 0001493152-25-011342
Filing Date
2025-07-23
Accepted
2025-07-23 08:16:16
Documents
15
Period of Report
2025-07-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 53809
2 EX-99.1 ex99-1.htm EX-99.1 20548
3 GRAPHIC ex99-1_001.jpg GRAPHIC 20227
  Complete submission text file 0001493152-25-011342.txt   280728

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aneb-20250723.xsd EX-101.SCH 3011
5 XBRL LABEL FILE aneb-20250723_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE aneb-20250723_pre.xml EX-101.PRE 22356
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4003
Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734
Business Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40388 | Film No.: 251141673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)